Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$60,417,671
+$1,012,050 QoQ
Shares Held
318,625
+5.8% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#152
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 59%
Shared 23%
None 17%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cerity Partners LLC holds $2,389,117,165 across 15 Drug Manufacturers - General names. AZN ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
747,548 | $896,631,571 | |
| 2 | JNJ |
Johnson & Johnson
|
1,872,006 | $475,433,362 | |
| 3 | ABBV |
AbbVie Inc.
|
1,275,203 | $320,892,081 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,567,712 | $201,450,991 | |
| 5 | AMGN |
Amgen Inc
|
444,842 | $161,086,184 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,277,451 | $73,606,725 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
318,625 | $60,417,671 | |
| 8 | NVS |
Novartis AG
|
334,595 | $52,437,727 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,417,671 | 318,625 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $59,405,621 | 301,215 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||